Literature DB >> 16868771

Distribution of the glutamate transporters GLT-1 (SLC1A2) and GLAST (SLC1A3) in peripheral organs.

Urs V Berger1, Matthias A Hediger.   

Abstract

The glutamate transporters GLT-1 and GLAST are widely expressed in astrocytes in the brain where they fulfill important functions during glutamatergic neurotransmission. The present study examines their distribution in peripheral organs using in situ hybridization (ISH) and immunocytochemistry. GLAST was found to be more widely distributed than GLT-1. GLAST was expressed primarily in epithelial cells, cells of the macrophage-lineage, lymphocytes, fat cells, interstitial cells, and salivary gland acini. GLT-1 was primarily expressed in glandular tissue, including mammary gland, lacrimal gland, and ducts and acini in salivary glands, but also by perivenous hepatocytes and follicular dendritic cells in spleen and lymph nodes. The findings demonstrate that, although expressed by the same cells in the brain, these two glutamate transporters have different distribution patterns in peripheral tissues and that they fulfill glutamate transport functions apart from glutamatergic neurotransmission in these areas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868771     DOI: 10.1007/s00429-006-0109-x

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  24 in total

1.  Differential expression of the glutamate transporter GLT-1 in pancreas.

Authors:  James S Meabon; Aven Lee; Kole D Meeker; Lynn M Bekris; Robert K Fujimura; Chang-En Yu; G Stennis Watson; David V Pow; Ian R Sweet; David G Cook
Journal:  J Histochem Cytochem       Date:  2011-11-22       Impact factor: 2.479

2.  Human nasal olfactory epithelium as a dynamic marker for CNS therapy development.

Authors:  Rita Sattler; Yoko Ayukawa; Luke Coddington; Akira Sawa; David Block; Richard Chipkin; Jeffrey D Rothstein
Journal:  Exp Neurol       Date:  2011-09-16       Impact factor: 5.330

Review 3.  The functional and molecular entities underlying amino acid and peptide transport by the mammary gland under different physiological and pathological conditions.

Authors:  D B Shennan; C A R Boyd
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-25       Impact factor: 2.673

4.  Expression of Glutamate Transporters in Mouse Liver, Kidney, and Intestine.

Authors:  Qiu Xiang Hu; Sigrid Ottestad-Hansen; Silvia Holmseth; Bjørnar Hassel; Niels Christian Danbolt; Yun Zhou
Journal:  J Histochem Cytochem       Date:  2018-01-05       Impact factor: 2.479

5.  Visualizing the brain's astrocytes.

Authors:  Alyssa N Preston; Danielle A Cervasio; Scott T Laughlin
Journal:  Methods Enzymol       Date:  2019-03-04       Impact factor: 1.600

Review 6.  GLAST But Not Least--Distribution, Function, Genetics and Epigenetics of L-Glutamate Transport in Brain--Focus on GLAST/EAAT1.

Authors:  Omar Šerý; Nilufa Sultana; Mohammed Abul Kashem; David V Pow; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2015-05-14       Impact factor: 3.996

7.  Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease.

Authors:  Kole D Meeker; James S Meabon; David G Cook
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Elevated systemic glutamic acid level in the non-obese diabetic mouse is Idd linked and induces beta cell apoptosis.

Authors:  Viqar Showkat Banday; Kristina Lejon
Journal:  Immunology       Date:  2016-10-20       Impact factor: 7.397

9.  Proteome analysis and conditional deletion of the EAAT2 glutamate transporter provide evidence against a role of EAAT2 in pancreatic insulin secretion in mice.

Authors:  Yun Zhou; Leonie F Waanders; Silvia Holmseth; Caiying Guo; Urs V Berger; Yuchuan Li; Anne-Catherine Lehre; Knut P Lehre; Niels C Danbolt
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

Review 10.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.